Teva Pharmaceutical Industries (TEVA) Property, Plant & Equipment (Net) (2009 - 2026)
Analysis
Teva Pharmaceutical Industries (TEVA) Property, Plant & Equipment (Net) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn | 3.93 Bn |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | 2.44 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 1.22 Bn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 456.88 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 381.58 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 73.22 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | 389.13 Mn |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | 49,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.93 Bn |
| Mar 31, 2026 | 4.00 Bn |
| Dec 31, 2025 | 4.08 Bn |
| Sep 30, 2025 | 4.82 Bn |
| Jun 30, 2025 | 4.81 Bn |
| Mar 31, 2025 | 4.63 Bn |
| Dec 31, 2024 | 4.58 Bn |
| Sep 30, 2024 | 5.67 Bn |
| Jun 30, 2024 | 5.57 Bn |
| Mar 31, 2024 | 5.62 Bn |
| Dec 31, 2023 | 5.75 Bn |
| Sep 30, 2023 | 5.62 Bn |
| Jun 30, 2023 | 5.71 Bn |
| Mar 31, 2023 | 5.75 Bn |
| Dec 31, 2022 | 5.74 Bn |
| Sep 30, 2022 | 5.57 Bn |
| Jun 30, 2022 | 5.74 Bn |
| Mar 31, 2022 | 5.93 Bn |
| Dec 31, 2021 | 5.98 Bn |
| Sep 30, 2021 | 6.04 Bn |